Pulmonx gets CE mark for emphysema device; DoD is focused on diagnostics;

 @FierceMedDev: Bacterin International, a maker of bone graft material and antimicrobial coatings, won $25M in financing from OrbiMed. Release | Follow @FierceMedDev

 @MarkHFierce: BSX is slashing more jobs and splitting its cardio business in two--undoing changes enacted by the old CEO. More | Follow @MarkHFierce

 @DamianFierce: Baxter is recalling four Automix devices over a deadly malfunction risk. The FDA has labeled it a Class I. News | Follow @DamianFierce

> Pulmonx got a CE mark for the Zephyr endobronchial valve, targeted to relieve hyperinflation associated with emphysema. More

> The Department of Defense is reaffirming its commitment to diagnostics, saying it wants to increase the use of in-the-field assays to keep soldiers safe. Story

> CareFusion ($CFN) is delaying filing its annual report to discuss the use of an alternative accounting method with the SEC. Article

> India's Consure Medical has pulled in an undisclosed investment from the India Innovation Fund and Indian Angel Network to launch a device designed to treat fecal incontinence, estimated to affect more than 16 million people in India and 100 million  worldwide. News

> Diagnostics firm Polymedco has signed a licensing deal to allow MedPrimex to sell its fecal immunochemical test for screening colorectal cancer in Mexico. Report

> Diagnostics firm GeneCentric is now officially launched, looking to market two lung cancer diagnostics using technologies licensed from the University of North Carolina at Chapel Hill. Release

> Medgenics ($MDGN) got regulatory approval in Israel to start clinical trials for Infradure, a tissue implant designed to treat hepatitis C. Item

Biotech News

 @FierceBiotech: XBiotech hatches big plans for Austin campus. Item | Follow @FierceBiotech

 @JohnCFierce: At long last, Ironwood gets its OK, shifts to commercialization alongside development. News | Follow @JohnCFierce

 @RyanMFierce: After reading through this OvaScience S-1, looks like VCs are in fact cashing out, some want to unload most of their shares. | Follow @RyanMFierce

> Cincy biotech spinoff snags $27M A round for vascular drug work. Story

> Novartis ready to present blockbuster COPD hopeful QVA149 to regulators. Article

> Teva's Neupogen-knockoff approval highlights slow progress of biosims. More

> J&J grabs Genmab's promising leukemia antibody in $1.1B deal. News

Pharma News

 @FiercePharma: Two drugmakers hit the Forbes "Fab 50" in Asia: Australia's CSL and India's Sun Pharma. Item | Follow @FiercePharma

> Novartis begs vets for loyalty through animal drug shortages. Article

> Avastin tops list of most-requested cancer meds in U.K. Report

> FDA flags cataract risk in kids using Vertex's Kalydeco. Story

Pharma Manufacturing News

 @EricPFierce: Hospira goes back to Orchid, picks up API plant, R&D center for $200 million. Good news tainted a bit by FDA warning. Story | Follow @EricPFierce

> Closed plants lead Novartis to plead for vet loyalty. Story

> Claris squares off against former partners in U.S. injectables market. Article

> Scots reject GSK wind turbines; tidal turbines up next. Story

Vaccines News

 @AlisonBFierce: What does AstraZeneca's new CEO mean to vaccinemaker MedImmune? More | Follow @AlisonBFierce

> S. Korea, Sweden partner up to find Alzheimer's vaccine. Item

> West Nile virus breaks out in the South. News

> CSL nets closeout letter after FDA violations. More

> Flu adjuvant adds promise to vaccine. Report